View of Therapeutic Potential of the Dual Peroxisome Proliferator Activated Receptor (PPAR)/ Agonist Aleglitazar in Attenuating TNF-mediated Inflammation and Insulin Resistance in Human Adipocytes: A Review

Return to Article Details Therapeutic Potential of the Dual Peroxisome Proliferator Activated Receptor (PPAR)/ Agonist Aleglitazar in Attenuating TNF-mediated Inflammation and Insulin Resistance in Human Adipocytes: A Review Download Download PDF